[
  {
    "ts": null,
    "headline": "Campbell's Stock: No Longer Attractive As Sales Decline (Downgrade)",
    "summary": "Discover why The Campbell's Company's organic growth is declining amid snack sales pressure from GLP-1 drug trends. Click for my CPB stock update.",
    "url": "https://finnhub.io/api/news?id=de4a41f2c3cc9bfa27244f53301fa2932be48e8ec8eb336bb40a3a6b196a4bf5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747753949,
      "headline": "Campbell's Stock: No Longer Attractive As Sales Decline (Downgrade)",
      "id": 134618696,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/481679010/image_481679010.jpg?io=getty-c-w1536",
      "related": "CPB",
      "source": "SeekingAlpha",
      "summary": "Discover why The Campbell's Company's organic growth is declining amid snack sales pressure from GLP-1 drug trends. Click for my CPB stock update.",
      "url": "https://finnhub.io/api/news?id=de4a41f2c3cc9bfa27244f53301fa2932be48e8ec8eb336bb40a3a6b196a4bf5"
    }
  }
]